LifeScan (the "Company"), a world leader in blood glucose monitoring, today announced its successful emergence from its Chapter 11 financial restructuring process following approval of its Plan of ...
The partnership announced in March between Johnson & Johnson subsidiary LifeScan and diabetes management company WellDoc has entered a new stage with a commercial partnership agreement, the companies ...
LifeScan Inc. (“LifeScan” or the “Company”), a world leader in blood glucose monitoring, today announced that its Chapter 11 Plan of Reorganization (the “Plan”) has been approved bythe United States ...
The FDA has cleared the wireless integration of one of Johnson and Johnson subsidiary LifeScan’s blood glucose monitoring systems and WellDoc’s digital diabetes management platform for people with ...
Johnson & Johnson will sell its LifeScan diabetes unit to the private equity firm Platinum Equity for $2.1 billion, reports CNBC. 1. LifeScan, which produces blood glucose monitoring products, ...
Blood glucose monitor with box, bottle of normal glucose control, test strips, At-a-Glance guide, warranty card, procedures guide, carrying case, logbook, and owner's manual. Blood glucose monitor is ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/19adcf/lifescan_medical_d) has announced the addition of the "Lifescan ...
(Reuters) - Johnson & Johnson said on Friday it was offered about $2.1 billion for its LifeScan Inc unit, which makes blood glucose monitoring products, by private equity firm Platinum Equity, another ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback